Michael DiTolla
Director at Biolase, Inc (BIOL)
Michael DiTolla has filed 1 insider report with the SEC since June 2021, as director at Biolase, Inc (BIOL). The latest filing, on June 15, 2021, reports grant or award at Biolase, Inc (BIOL).
- Filings
- 1
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Michael DiTolla is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | Jun 15, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
Questions about Michael DiTolla
- What is Michael DiTolla's role at Biolase, Inc?
- Michael DiTolla reports to the SEC as director at Biolase, Inc (BIOL), according to the latest filing on June 15, 2021.
- Has Michael DiTolla bought or sold stock recently?
- No open-market purchases or sales by Michael DiTolla are on file. The filings report grant or award.
- How do I get alerts when Michael DiTolla files?
- Follow Michael DiTolla on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Michael DiTolla (SEC CIK 0001794696). Totals count each trade once, skipping amendments whose original is on file, from Jun 15, 2021 on. View on SEC EDGAR